Carol L Brosgart - Net Worth and Insider Trading

Carol L Brosgart Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol L Brosgart owns 3 companies in total, including Renovaro Inc (RENB) , Regado Biosciences Inc (RGDO) , and Mirum Pharmaceuticals Inc (MIRM) .

Click here to see the complete history of Carol L Brosgart’s form 4 insider trades.

Insider Ownership Summary of Carol L Brosgart

Ticker Comapny Transaction Date Type of Owner
RENB Renovaro Inc 2019-12-27 director
RGDO Regado Biosciences Inc 2016-11-01 director
MIRM Mirum Pharmaceuticals Inc 2021-06-04 director

Carol L Brosgart Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carol L Brosgart Ownership Network

Ownership Network List of Carol L Brosgart

No Data

Ownership Network Relation of Carol L Brosgart


Carol L Brosgart Owned Company Details

What does Renovaro Inc do?

Who are the key executives at Renovaro Inc?

Carol L Brosgart is the director of Renovaro Inc. Other key executives at Renovaro Inc include 10 percent owner Ole Abildgaard , Executive Vice President Francois Binette , and 10 percent owner Serhat Gumrukcu .

Renovaro Inc (RENB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Renovaro Inc (RENB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Renovaro Inc (RENB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Renovaro Inc (RENB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Renovaro Inc Insider Transactions

No Available Data

Carol L Brosgart Mailing Address

Above is the net worth, insider trading, and ownership report for Carol L Brosgart. You might contact Carol L Brosgart via mailing address: C/o Tobira Therapeutics, Inc., 701 Gateway Boulevard, South San Francisco Ca 94080.

Discussions on Carol L Brosgart

No discussions yet.